FDA Approval Sends Two Stocks Soaring

Vinco Ventures Pops After Hype Surrounding Gamma Squeeze [Trade of the Day Wake-Up Watchlist] Good morning Wake-Up Watchlisters! While you’re sipping coffee for the daily rise and grind you’ll see stock futures rose Monday. Investors are waiting for inflation data this week. Back in August, the consumer price index rose 8.1% over the prior year, a moderation from an 8.5% increase in July. There’s no doubt inflation has hit wallets hard in 2022, which is why you need to protect your assets. [Precious Metal IRAs]( could be a way to help keep your retirement in tact. And if your account qualifies, you can receive up to $10,000 or more in FREE silver. [Click here to learn more about Precious Metal IRAs.]( Here’s a look at the top-moving stocks this morning. Spectrum Pharmaceuticals (Nasdaq: SPPI) Spectrum Pharmaceuticals is up 20.46% premarket after the company received FDA approval for its Rolvedon™ drug. The approval marks Spectrum’s transformation to a commercial-stage company with the opportunity to compete in a $2 billion market. The medical sector often provides some amazing investment opportunities. And our friend Alexander Green wants you to know about this [new breakthrough technology](. Its company is trading at just $3 and has only been public since 2020. [Click here to discover this company.]( Bristol-Myers Squibb Company (NYSE: BMY) Bristol-Myers Squibb Company is up 6.90% premarket after the FDA approved its new plaque psoriasis treatment. The drug goes by the name ‘Sotyktu’ and is the first new treatment for adults suffering from moderate-to-severe plaque psoriasis in more than ten years. Bristol Myers says the drug could launch as early as next month. [Investors Quitting by the Hordes]( Record inflation... rising interest rates... and stocks that keep tumbling. Is it all over?! Countless investors chose to QUIT the stock market [after seeing this](. Carvana Co. (Nasdaq: CVNA) Carvana is up 6.04% premarket after the online car retailer recently made its vehicle financing qualification process even easier by offering Nashville residents a co-signer option. Shares of Carvana have been one of the biggest beneficiaries of the COVID rally. Plus, several billionaires including Jim Simons’ Renaissance Technologies and Israel Englander’s Millennium Management, just purchased 1,249 million shares and 504,725 shares, respectively. We recently closed a trade on Carvana in [The War Room]( for a double-digit gain. [Click here to unlock that trade.]( Vinco Ventures (Nasdaq: BBIG) Vinco Ventures is up 11% premarket and shares have recently doubled in the span of a few days. One of the key drivers has been hype surrounding a potential gamma squeeze. According to Twitter personality Will Meade, Vinco Ventures is currently in 5th place in terms of gamma squeeze opportunities. Those are the top market movers today. Happy trading! The Wake-Up Watchlist Research Team [8,000X Better Than Savings... in ONE Day?!]( Oxford Club Chief Income Strategist Marc Lichtenfeld just made an incredible discovery... A group of stocks that have handed out more than 8,000X what the average savings account pays in a year... in just ONE day. And if you know exactly where to look... Starting this earnings season, you could have a shot at gains like these. [>> Get the Details HERE.]( [Monument Traders Alliance] Monument Traders Alliance You are receiving this email because you subscribed to Trade of the Day Wake-Up Watchlist. To unsubscribe from Trade of the Day Wake-Up Watchlist, [click here](. Questions? Check out our [FAQs](. Trying to reach us? [Contact us here.]( Please do not reply to this email as it goes to an unmonitored inbox. To cancel by mail or for any other subscription issues, write us at: Trade of the Day | 14 West Mount Vernon Place | Baltimore, MD 21201 North America: 1.800.507.1399 | International: +1.443.353.4977 [Website]( | [Privacy Policy]( Keep the emails you value from falling into your spam folder. [Whitelist Trade of the Day](. © 2022 Monument Traders Alliance, LLC | All Rights Reserved Nothing published by Monument Traders Alliance should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investment advice. We expressly forbid our writers from having a financial interest in their own securities recommendations to readers. All of our employees and agents must wait 24 hours after online publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended by Monument Traders Alliance should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.